Poster Session 3-25 MM: Prognostic factors/Imaging

[PS3-25-5] Prognostic factors for myeloma patients in Revised International Staging System stage II

Ryosuke Kinoshita¹, Mariko Ishibashi², Koiti Inokuchi¹, Hiroshi Handa³, Makoto Sasaki⁴, Norio Komatsu⁴, Yoichi Imai⁵, Norina Tanaka⁶, Junji Tanaka⁶, Sakae Tanosaki⁷, Shigeki Ito⁸, Atsushi Isoda⁹, Morio Matsumoto⁹, Michiaki Koike¹⁰, Hideto Tamura¹ (1.Department of Hematology, Nippon Medical School, 2.Department of Microbiology and Immunology, Nippon Medical School, 3.Department of Hematology, Gunma University, 4.Division of Hematology, Juntendo University School of Medicine, 5.Department of Hematology and Oncology, IMSUT Hospital, 6.Department of Hematology, Tokyo Women's Medical University, 7.Department of Hematology, The Fraternity Memorial Hospital, 8.Department of Clinical Oncology, Iwate Medical University School of Medicine, 9.Department of Hematology, National Hospital Organization Shibukawa Medical Center, 10.Department of Hematology, Juntendo University Shizuoka Hospital)